Literature DB >> 16883157

Preoperative embolization of hypervascular spinal metastases using percutaneous direct injection with n-butyl cyanoacrylate: technical case report.

Clemens M Schirmer1, Adel M Malek, Eddie S Kwan, Daniel A Hoit, Simcha J Weller.   

Abstract

OBJECTIVE: Intraoperative blood loss constitutes a major cause of perioperative morbidity in surgical decompression and reconstruction of highly vascular spinal metastatic tumors. We propose a technique for embolization of highly vascular vertebral metastases using percutaneous direct injection using n-butyl cyanoacrylate (NBCA) instead of polymethylmethacrylate to complement preoperative transarterial embolization and to minimize operative blood loss.
METHODS: Five patients with renal cell carcinoma metastases to the spine (one cervical, one thoracic, and three lumbar) underwent embolization by percutaneous direct injection of the affected vertebrae with a mixture of NBCA and iodized oil to supplement transarterial embolization with polyvinyl alcohol particles and fibered platinum coils. This was achieved via a transpedicular approach in four cases and by direct vertebral body puncture in one case.
RESULTS: The percutaneous NBCA direct injection procedure was technically successful in all cases and was not associated with neurological or medical complications. All patients underwent subsequent vertebrectomy and spinal instrumentation. Surgical resection was performed with lower than expected blood loss and with a subjective improvement in tumor tissue handling and dissection.
CONCLUSION: The extent of tumor devascularization can be improved by supplementing transarterial embolization with NBCA direct injection to decrease operative blood loss and increase the safety of surgical resection and stabilization of highly vascular spinal metastases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883157     DOI: 10.1227/01.NEU.0000223503.92392.CE

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

Review 1.  Spinal cord compression in cancer patients: review of diagnosis and treatment.

Authors:  Marta Penas-Prado; Monica E Loghin
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

2.  Embolization of musculoskeletal bone tumors.

Authors:  Richard J T Owen
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

3.  Three-dimensional characterization of the vascular bed in bone metastasis of the rat by microcomputed tomography (MicroCT).

Authors:  Hervé Nyangoga; Philippe Mercier; Hélène Libouban; Michel Félix Baslé; Daniel Chappard
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

Review 4.  Interventional management of vertebral body metastases.

Authors:  Ethan A Prince; Sun Ho Ahn
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

5.  Percutaneous osteoplasty for hypervascular bone metastasis.

Authors:  Makoto Shinoto; Kanehiro Hasuo; Hitoshi Aibe; Yoshitaka Shida; Maya Kinjo; Yuko Kubo; Kotaro Terashima
Journal:  Radiat Med       Date:  2009-01-08

6.  Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition.

Authors:  Yoshito Takeuchi; Hiroyuki Morishita; Yozo Sato; Shingo Hamaguchi; Noriaki Sakamoto; Hiroyuki Tokue; Takafumi Yonemitsu; Kenji Murakami; Hiroyasu Fujiwara; Keitaro Sofue; Toshi Abe; Hideyuki Higashihara; Yasuo Nakajima; Morio Sato
Journal:  Jpn J Radiol       Date:  2014-06-03       Impact factor: 2.374

7.  Quantification of vertebral involvement in metastatic spinal disease.

Authors:  Ricardo Vieira Botelho; Matheus Fernandes de Oliveira; Jose Marcus Rotta
Journal:  Open Orthop J       Date:  2013-08-19

8.  Epidural haemorrhage during embolisation: a rare complication of intra-arterial embolisation of vertebral metastases.

Authors:  H Hashim; Ka Abdul Kadir
Journal:  Biomed Imaging Interv J       Date:  2011-10-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.